Arkansas Research Alliance Aligns With FDA on Commercialization

by Mark Carter  on Wednesday, Sep. 11, 2013 9:09 am  

FDA Commissioner Margaret Hamburg and Arkansas Research Alliance CEO Jerry Adams sign a partnership deal between FDA and ARA.

Adams credited Hamburg and Beebe for their diligence in supporting the MOU, as well as former NCTR deputy director, current ARA consultant and "PIA catalyst" Art Norris, who authored the MOU

According to ARA, further results from the MOU include: 

  • The establishment of a virtual Arkansas Center of Excellence in Regulatory Science. Regulatory science assures that products are safe and effective.
  • The creation of a working group to guide its implementation. Beebe appointed Mary Good, chair of the Emerging Analytics Center Management Board and a special adviser on economic development at UALR, and NCTR director William Slikker to co-chair the group.
  • The early stages of a collaborative research program in the area of bioinformatics. Bioinformatics combines the science of information technology with biological sciences.
  • A provision to develop other mechanisms of partnership between private business, the state's research universities and the federal government.

Adams called the graphene research that entails each of the state's research universities potentially of international significance. "We've had excellent collaborative progress on graphene," he said.

Earlier this month, Adams joined researchers from four of the state's research universities on Petit Jean Mountain to share ideas on collaboration and commercialization. Adams thinks the collaborative nature of Arkansans is another asset to be leveraged.

Of the PIA, Adams said, "This will be really what we make of it. This puts intentionality and structure around the process."

 

 

Please read our comments policy before commenting.